EDGAR Filing Documents for 0001193125-09-069221

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-09-069221

Filing Date

2009-03-31

Accepted

2009-03-31 15:12:33

Documents

Period of Report

2008-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	1101968
2	SECOND AMENDMENT TO LEASE, BY AND BETWEEN TRANSCEPT AND POINT RICHMOND R&D	dex1032.htm	EX-10.32	32028
3	LEASE, BY AND BETWEEN TRANSCEPT & POINT RICHMOND R&D ASSOCIATES II, LLC	dex1033.htm	EX-10.33	401145
4	OFFER LETTER	dex1034.htm	EX-10.34	20902
5	CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT	dex1035.htm	EX-10.35	52711
6	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	dex231.htm	EX-23.1	1965
7	CERTIFICATION OF THE COMPANY'S CEO PURSUANT TO SECTION 302	dex311.htm	EX-31.1	9335
8	CERTIFICATION OF THE COMPANY'S CFO PURUSANT TO SECTION 302	dex312.htm	EX-31.2	9473
9	CERTIFICATION OF THE COMPANY'S CEO & CFO PURSUANT TO SECTION 906	dex321.htm	EX-32.1	3833
10	GRAPHIC	g70436exa_p58.jpg	GRAPHIC	226930
11	GRAPHIC	g70436exa_p61.jpg	GRAPHIC	169805
12	GRAPHIC	g70436exa_p62.jpg	GRAPHIC	62963
13	GRAPHIC	g70436exa_p69.jpg	GRAPHIC	77387
14	GRAPHIC	g70436exa_p70.jpg	GRAPHIC	90873
15	GRAPHIC	g70436exa_p71.jpg	GRAPHIC	104682
16	GRAPHIC	g70436exa_p72.jpg	GRAPHIC	92142
17	GRAPHIC	g70436exa_p73.jpg	GRAPHIC	51453
18	GRAPHIC	g70436g22k63.jpg	GRAPHIC	36543
19	GRAPHIC	g70436g57l84.jpg	GRAPHIC	33012
20	GRAPHIC	g70436g61o87.jpg	GRAPHIC	36104
21	GRAPHIC	g70436g69a27.jpg	GRAPHIC	44332
22	GRAPHIC	g70436g71g52.jpg	GRAPHIC	45199
23	GRAPHIC	g70436g88i65.jpg	GRAPHIC	33486
24	GRAPHIC	g70436g95a02.jpg	GRAPHIC	75179
	Complete submission text file	0001193125-09-069221.txt		3263044

Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804

Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500

Transcept Pharmaceuticals Inc (Filer) CIK: 0001178711 (see all company filings)

Filing Detail